SCHEMBL1126482

SCHEMBL1126482

CC(C)C[Al+]CC(C)C.O=[N+]([O-])c1ccc(CO)nc1.[H-]

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.40
SMN1; SMN2 Q16637 3/20 0.40
KDM4E B2RXH2 1/20 0.40
CYP1A2 P05177 1/20 0.40
GAA P10253 1/20 0.40
MAPT P10636 3/20 0.39
POLB P06746 3/20 0.39
NPC1 O15118 2/20 0.39
RAB9A P51151 2/20 0.39
KMT2A Q03164 2/20 0.39
MEN1 O00255 1/20 0.39
CYP2C19 P33261 2/20 0.38
ADRA2A P08913 2/20 0.38
ADRA2B P18089 2/20 0.38
ADRA2C P18825 2/20 0.38
SLC2A1 P11166 1/20 0.38
PKM P14618 1/20 0.37
HSP90AA1 P07900 1/20 0.35
CXCR5 P32302 1/20 0.35
APLNR P35414 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1126175 0.84 ADRA2A (0.49) ALDH1A1SMN1; SMN2KDM4ECYP1A2GAA
SCHEMBL18399532 0.74 POLB (0.46) ALDH1A1SMN1; SMN2CYP1A2GAAMAPT
SCHEMBL4209119 0.72 MAPK1 (0.47) ALDH1A1KDM4EGAAMAPTNPC1
SCHEMBL14658480 0.71 TSHR (0.55) ALDH1A1SMN1; SMN2KDM4ECYP1A2GAA
SCHEMBL5380629 0.71 CYP1A2 (0.47) ALDH1A1SMN1; SMN2KDM4ECYP1A2GAA
SCHEMBL20919073 0.71 MAPT (0.44) ALDH1A1SMN1; SMN2CYP1A2GAAMAPT
SCHEMBL11419834 0.69 HSPB1 (0.50) ALDH1A1SMN1; SMN2KDM4EMAPTPOLB
SCHEMBL8200767 0.68 POLB (0.49) ALDH1A1SMN1; SMN2KDM4ECYP1A2GAA
SCHEMBL4873349 0.68 MAPT (0.45) ALDH1A1SMN1; SMN2KDM4ECYP1A2GAA
SCHEMBL14399403 0.68 MAPT (0.45) ALDH1A1SMN1; SMN2KDM4ECYP1A2GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2282995-A1 DERIVATIVES OF QUINOLINES AND QUINOXALINES AS PROTEIN TYROSINE KINASE INHIBITORS Novartis AG (CH) 2011-02-16 EP disclosed
WO-2009141386-A1 DERIVATIVES OF QUINOLINES AND QUINOXALINES AS PROTEIN TYROSINE KINASE INHIBITORS NOVARTIS AG (CH) 2009-11-26 WO disclosed